Larry M. Tiffany
Président chez Medcura, Inc.
Profil
Larry M.
Tiffany was the founder of DioGenix, Inc. (founded in 2008) where he held the title of President, Chief Executive Officer & Director.
He is currently the Executive Chairman at Medcura, Inc. Mr. Tiffany's former positions include Senior Vice President & General Manager-Genomics at Gene Logic, Inc. (2006-2008), Senior Vice President at Ore Pharmaceuticals, Inc., and Chief Business Officer at Genetraks Pty Ltd.
Mr. Tiffany's education history includes a graduate degree from The Johns Hopkins University, an undergraduate degree from Nazareth College of Rochester (New York), and a graduate degree from the University of New Hampshire School of Law.
Postes actifs de Larry M. Tiffany
| Sociétés | Poste | Début |
|---|---|---|
Medcura, Inc.
 Medcura, Inc. Medical SpecialtiesHealth Technology Medcura, Inc. develops novel line of hemostatic and wound treatment products. The firm?s products include vascular gel-e, nuisance bleed, chronic wound, and surgical gel-e. The company was founded by Matthew Dowling in January 2013 and is headquartered in Riverdale, MD. | Président | - |
Anciens postes connus de Larry M. Tiffany
| Sociétés | Poste | Fin |
|---|---|---|
Ore Pharmaceuticals, Inc.
 Ore Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ore Pharmaceuticals, Inc. operates as a drug development company, which developed drug candidates for therapeutic uses. The firm marketed its drug repositioning capabilities to pharmaceutical companies based in North America, Japan and Europe. The company was founded in September 1994 and was headquartered in Wellesley, MA. | Corporate Officer/Principal | 14/09/2008 |
Gene Logic, Inc.
 Gene Logic, Inc. BiotechnologyHealth Technology Gene Logic, Inc. provides drug discovery and development services to pharmaceutical and biotechnology companies worldwide. The company operates in three segments: Genomics and Toxicogenomics Services, Preclinical Contract Research Services, and Drug Repositioning and Selection Services. Gene Logic was incorporated in 1994 and is headquartered in Gaithersburg, Maryland. | Corporate Officer/Principal | 03/01/2008 |
Genetraks Pty Ltd.
 Genetraks Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Genetraks Pty Ltd. operates as an Australian development stage company. The private company is based in TOOWONG, Australia. | Corporate Officer/Principal | - |
DioGenix, Inc.
 DioGenix, Inc. Medical SpecialtiesHealth Technology DioGenix, Inc. develops and commercializes novel, non-invasive diagnostic, prognostic and treatment response monitoring tests. Its program is designed to provide neurologists with a comprehensive set of clinical tests to diagnose early-stage MS, segment MS patients into clinical sub-types and predict response to treatment, all using non-invasive blood tests. The company was founded by Cam Gallagher, Douglas W. Bigwood and Larry M. Tiffany in September 2008 and is headquartered in Gaithersburg, MD. | Fondateur | - |
Formation de Larry M. Tiffany
| The Johns Hopkins University | Graduate Degree |
| Nazareth College of Rochester (New York) | Undergraduate Degree |
| University of New Hampshire School of Law | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Gene Logic, Inc.
Gene Logic, Inc. BiotechnologyHealth Technology Gene Logic, Inc. provides drug discovery and development services to pharmaceutical and biotechnology companies worldwide. The company operates in three segments: Genomics and Toxicogenomics Services, Preclinical Contract Research Services, and Drug Repositioning and Selection Services. Gene Logic was incorporated in 1994 and is headquartered in Gaithersburg, Maryland. | Health Technology |
Ore Pharmaceuticals, Inc.
Ore Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ore Pharmaceuticals, Inc. operates as a drug development company, which developed drug candidates for therapeutic uses. The firm marketed its drug repositioning capabilities to pharmaceutical companies based in North America, Japan and Europe. The company was founded in September 1994 and was headquartered in Wellesley, MA. | Health Technology |
DioGenix, Inc.
DioGenix, Inc. Medical SpecialtiesHealth Technology DioGenix, Inc. develops and commercializes novel, non-invasive diagnostic, prognostic and treatment response monitoring tests. Its program is designed to provide neurologists with a comprehensive set of clinical tests to diagnose early-stage MS, segment MS patients into clinical sub-types and predict response to treatment, all using non-invasive blood tests. The company was founded by Cam Gallagher, Douglas W. Bigwood and Larry M. Tiffany in September 2008 and is headquartered in Gaithersburg, MD. | Health Technology |
Genetraks Pty Ltd.
Genetraks Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Genetraks Pty Ltd. operates as an Australian development stage company. The private company is based in TOOWONG, Australia. | Commercial Services |
Medcura, Inc.
Medcura, Inc. Medical SpecialtiesHealth Technology Medcura, Inc. develops novel line of hemostatic and wound treatment products. The firm?s products include vascular gel-e, nuisance bleed, chronic wound, and surgical gel-e. The company was founded by Matthew Dowling in January 2013 and is headquartered in Riverdale, MD. | Health Technology |